Lukas S Tombor,Till Lautenschläger,Simone F Glaser,Ariane Fischer,Maximilian Merten,Susanne Hille,Oliver Müller,Christian Kupatt,Tarik Bozoglu,Christoph Kugler,Haider Sami,Manfred Ogris,Kathrin A Stilz,Josefine Panthel,Marion Muhly-Reinholz,Lisa-Maria Kettenhausen,Lukas Zanders,Leonie Stein,Paul Kiessling,Florian Sicklinger,Florian Leuschner,Bianca Schuhmacher,Mauro Siragusa,David Rodriguez Morales,David John,Haris Kujundzic,Minh-Thuy Katschke,Emmanouil G Solomonidis,Guillermo Luxán,Stephanie Hehlgans,Franz Rödel,Christoph Kuppe,Wesley T Abplanalp,Sebastian Cremer,Stefanie Dimmeler
{"title":"Immunoregulatory Endothelial Cells Interact With T Cells After Myocardial Infarction.","authors":"Lukas S Tombor,Till Lautenschläger,Simone F Glaser,Ariane Fischer,Maximilian Merten,Susanne Hille,Oliver Müller,Christian Kupatt,Tarik Bozoglu,Christoph Kugler,Haider Sami,Manfred Ogris,Kathrin A Stilz,Josefine Panthel,Marion Muhly-Reinholz,Lisa-Maria Kettenhausen,Lukas Zanders,Leonie Stein,Paul Kiessling,Florian Sicklinger,Florian Leuschner,Bianca Schuhmacher,Mauro Siragusa,David Rodriguez Morales,David John,Haris Kujundzic,Minh-Thuy Katschke,Emmanouil G Solomonidis,Guillermo Luxán,Stephanie Hehlgans,Franz Rödel,Christoph Kuppe,Wesley T Abplanalp,Sebastian Cremer,Stefanie Dimmeler","doi":"10.1161/circresaha.125.326145","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nEndothelial cells (ECs) play pivotal roles in maintaining cardiac blood supply and regulating inflammation by acting as gatekeepers for immune cell activity. This study unveils a novel immunomodulatory function of cardiac ECs following myocardial infarction.\r\n\r\nMETHODS\r\nWe used single-cell RNA sequencing and spatial transcriptomics to identify EC states after acute myocardial infarction in mice. Subsequently, we mimicked the cytokine environment that was predicted to induce EC activation in cell culture studies and confirmed the results in an endothelial-specific deletion mouse model.\r\n\r\nRESULTS\r\nSingle-cell RNA sequencing analysis identified a transient myeloid CD45+CD11b+Cdh5+ immunomodulatory EC phenotype (IMEC) emerging between days 1 and 3 after myocardial infarction. IMECs derived from Cdh5+ tissue resident cells as shown by bone marrow transplantation and lineage tracing experiment. Ligand-receptor interaction predictions indicated a cytokine-mediated activation of IMECs, which we validated through in vitro experiments in cultured ECs. Notably, while cytokine treatment with IL-1β (interleukin 1β) and TGF-β (transforming growth factor β) induced mesenchymal gene expression, the addition of IFN-γ (interferon γ) facilitated the transition into the immunomodulatory phenotype. IMECs exhibited an upregulation of MHC-II (major histocompatibility complex class II) genes, along with the expression of RUNX1 and proinflammatory cytokines, such as IL-6 and IL-12. IMECs induced T-cell activation through paracrine signaling and were colocalized with T cells in vivo. Inhibition of endothelial-specific IFN-γ-signaling in mice by IFN-γ receptor 1 deletion improved the recovery after myocardial infarction.\r\n\r\nCONCLUSIONS\r\nThese findings provide insight into the role of ECs regulating adaptive immune responses following myocardial infarction, offering potential insights into therapeutic interventions for postinfarction immunomodulation.","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"68 1","pages":""},"PeriodicalIF":16.2000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/circresaha.125.326145","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Endothelial cells (ECs) play pivotal roles in maintaining cardiac blood supply and regulating inflammation by acting as gatekeepers for immune cell activity. This study unveils a novel immunomodulatory function of cardiac ECs following myocardial infarction.
METHODS
We used single-cell RNA sequencing and spatial transcriptomics to identify EC states after acute myocardial infarction in mice. Subsequently, we mimicked the cytokine environment that was predicted to induce EC activation in cell culture studies and confirmed the results in an endothelial-specific deletion mouse model.
RESULTS
Single-cell RNA sequencing analysis identified a transient myeloid CD45+CD11b+Cdh5+ immunomodulatory EC phenotype (IMEC) emerging between days 1 and 3 after myocardial infarction. IMECs derived from Cdh5+ tissue resident cells as shown by bone marrow transplantation and lineage tracing experiment. Ligand-receptor interaction predictions indicated a cytokine-mediated activation of IMECs, which we validated through in vitro experiments in cultured ECs. Notably, while cytokine treatment with IL-1β (interleukin 1β) and TGF-β (transforming growth factor β) induced mesenchymal gene expression, the addition of IFN-γ (interferon γ) facilitated the transition into the immunomodulatory phenotype. IMECs exhibited an upregulation of MHC-II (major histocompatibility complex class II) genes, along with the expression of RUNX1 and proinflammatory cytokines, such as IL-6 and IL-12. IMECs induced T-cell activation through paracrine signaling and were colocalized with T cells in vivo. Inhibition of endothelial-specific IFN-γ-signaling in mice by IFN-γ receptor 1 deletion improved the recovery after myocardial infarction.
CONCLUSIONS
These findings provide insight into the role of ECs regulating adaptive immune responses following myocardial infarction, offering potential insights into therapeutic interventions for postinfarction immunomodulation.
期刊介绍:
Circulation Research is a peer-reviewed journal that serves as a forum for the highest quality research in basic cardiovascular biology. The journal publishes studies that utilize state-of-the-art approaches to investigate mechanisms of human disease, as well as translational and clinical research that provide fundamental insights into the basis of disease and the mechanism of therapies.
Circulation Research has a broad audience that includes clinical and academic cardiologists, basic cardiovascular scientists, physiologists, cellular and molecular biologists, and cardiovascular pharmacologists. The journal aims to advance the understanding of cardiovascular biology and disease by disseminating cutting-edge research to these diverse communities.
In terms of indexing, Circulation Research is included in several prominent scientific databases, including BIOSIS, CAB Abstracts, Chemical Abstracts, Current Contents, EMBASE, and MEDLINE. This ensures that the journal's articles are easily discoverable and accessible to researchers in the field.
Overall, Circulation Research is a reputable publication that attracts high-quality research and provides a platform for the dissemination of important findings in basic cardiovascular biology and its translational and clinical applications.